Pregled bibliografske jedinice broj: 1214674
Šećerna bolest tip 1 u trudnoći: visoka incidencija novorođenčadi velike za gestacijsku dob unatoč adekvatnoj kontroli glikemije i niskoj glikemijskoj varijabilnosti
Šećerna bolest tip 1 u trudnoći: visoka incidencija novorođenčadi velike za gestacijsku dob unatoč adekvatnoj kontroli glikemije i niskoj glikemijskoj varijabilnosti // Endocrine Abstracts
Zagreb, Hrvatska: BioScientifica, 2022. str. 1-2 doi:10.1530/endoabs.83.domno3 (predavanje, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1214674 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Šećerna bolest tip 1 u trudnoći: visoka
incidencija novorođenčadi
velike za gestacijsku dob unatoč adekvatnoj
kontroli glikemije i niskoj
glikemijskoj varijabilnosti
(Type 1 diabetes mellitus in pregnancy: high
incidence of large-for-
gestational-age neonates despite adequate glycemic
control and low
glycemic variability)
Autori
G, Leksic ; M, Baretic ; L, Gudelj ; M, Radic ; M, Ivanisevic
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Endocrine Abstracts
/ - : BioScientifica, 2022, 1-2
Skup
9th ESE Young Endocrinologists and Scientists Meeting 2022 (EYES)
Mjesto i datum
Zagreb, Hrvatska, 02.09.2022. - 04.09.2022
Vrsta sudjelovanja
Predavanje
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
šećerna bolest tip 1, trudnoća, novorođenčad velika za gestacijsku dob
(type 1 diabetes mellitus, pregnancy, large-for-gestational-age neonates)
Sažetak
Background Pregnancy with type 1 diabetes mellitus (T1DM) carries risks for many adverse outcomes ; the most common are large-for-gestational-age neonates (LGA). Proper glycemic control reduces the risk for LGA. However, it occurs in almost 40% of T1DM pregnancies despite of achieving almost normoglycemia. Some studies suggested the contributing role of maternal body mass index (BMI) and glucovariability, but the effect on development of LGA still remains unclear. Objectives The aim of this study was to analyse incidence of LGA in planned and well- controlled T1DM pregnancies. Methods This prospective study included 42 patients with T1DM who were using continuous glucose monitoring (CGM) from preconception to delivery. Including criteria were preconception counselling, CGM at least 3 months prior to the study, duration of T1DM for at least 1 year, HbA1c ! 7.5%, BMI !25 kg/m2. Excluding criteria were HbA1c O7.5% and maternal weight gain O 20 kg in the 2nd and 3rd trimester. Patients used intermittently scanned CGM and data was analysed once in every trimester. Statistical analysis was performed with IBM SPSS software and data was defined as mean and standard deviation. Results In the first, second and third trimester time in range was 54.3G14.3, 62.4G 10.6, 67.5G11.7% respectively. Glucose management indicator was 6.5G0.5, 6.0G 0.4, 5.9G0.4% and %coefficient of variation 41.2G7.5, 38.6G5.9, 34.1G6.5% in the first, second and third trimester, respectively. Neonatal birth weight was 3594.3G632.2 grams, birth weight percentile 72.1G28.6 and 45% of neonates were LGA. Conclusions In this study we observed improved glycaemic control and decrease of glycemic variability from the first to the third trimester as a result of structured preconception counselling and strict follow-up. However, there was high incidence of LGA despite adequate glycemic control, low glycemic variability and normal BMI. Further studies for defining LGA aetiology in T1DM pregnancies are needed.
Izvorni jezik
Engleski
Znanstvena područja
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinička bolnica "Dubrava",
Klinički bolnički centar Zagreb
Profili:
Marina Ivanišević
(autor)